Regulation of macrophage polarization by RON receptor tyrosine kinase signaling

Frontiers in Immunology

Volumn 5, Issue OCT, 2014, Pages

  Chaudhuri, Amitabha ^a  

^a Genome Medical   (United States)

Author keywords

Immune therapy; Macrophages; Polarization; RON signaling; Tumor promotion

Indexed keywords

ARGINASE 1; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERFERON REGULATORY FACTOR; INTERLEUKIN 13; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; RON PROTEIN TYROSINE KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL MOTILITY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MACROPHAGE POLARIZATION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; SIGNAL TRANSDUCTION; TISSUE REPAIR; WOUND HEALING;

EID: 84919426734     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00546     Document Type: Article

References (43)

1. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol (2009) 27:669-92. doi: 10.1146/annurev.immunol.021908.132557
2. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science (2010) 327(5966):656-61. doi:10.1126/science.1178331
3. Terry RL, Miller SD. Molecular control of monocyte development. Cell Immunol (2014). doi:10.1016/j.cellimm.2014.02.008
4. Mills CD. M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol (2012) 32(6):463-88. doi:10.1615/CritRevImmunol.v32.i6.10
5. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 122(3):787-95. doi:10.1172/JCI59643
6. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep (2014) 6:13. doi:10.12703/P6-13
7. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity (2014) 41(1):14-20. doi:10.1016/j.immuni.2014.06.008
8. Ivashkiv LB. Epigenetic regulation of macrophage polarization and function. Trends Immunol (2013) 34(5):216-23. doi:10.1016/j.it.2012.11.001
9. Van Dyken SJ, Locksley RM. Interleukin-4-and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol (2013) 31:317-43. doi:10.1146/annurev-immunol-032712-095906
10. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity (2010) 32(5):593-604. doi:10.1016/j.immuni.2010.05.007
11. Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. ScientificWorldJournal (2011) 11:2391-402. doi:10.1100/2011/213962
12. Schenten D, Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv Immunol (2011) 109:87-124. doi:10.1016/B978-0-12-387664-5.00003-0
13. Medzhitov R. Pattern recognition theory and the launch of modern innate immunity. J Immunol (2013) 191(9):4473-4. doi:10.4049/jimmunol.1302427
14. Jenkins KA, Mansell A. TIR-containing adaptors in toll-like receptor signalling. Cytokine (2010) 49(3):237-44. doi:10.1016/j.cyto.2009.01.009
15. Mills CD. Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue. Crit Rev Immunol (2001) 21(5):399-425. doi:10.1615/CritRevImmunol.v21.i5.10
16. Zhou D, Huang C, Lin Z, Zhan S, Kong L, Fang C, et al. Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal (2014) 26(2):192-7. doi:10.1016/j.cellsig.2013.11.004
17. Babon JJ, Nicola NA. The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factors (2012) 30(4):207-19. doi:10.3109/08977194.2012.687375
18. Peti W, Page R. Molecular basis of MAP kinase regulation. Protein Sci (2013) 22(12):1698-710. doi:10.1002/pro.2374
19. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis (2010) 30(3):245-57. doi:10.1055/s-0030-1255354
20. Gadang V, Kohli R, Myronovych A, Hui DY, Perez-Tilve D, Jaeschke A. MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet. Am J Physiol Endocrinol Metab (2013) 305(4):E549-56. doi:10.1152/ajpendo.00197.2013
21. Luyendyk JP, Schabbauer GA, Tencati M, Holscher T, Pawlinski R, Mackman N. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J Immunol (2008) 180(6):4218-26. doi:10.4049/jimmunol.180.6.4218
22. Abad C, Gomariz R, Waschek J, Leceta J, Martinez C, Juarranz Y, et al. VIP in inflammatory bowel disease: state of the art. Endocr Metab Immune Disord Drug Targets (2012) 12(4):316-22. doi:10.2174/187153012803832576
23. Arranz A, Doxaki C, Vergadi E, Martinez de la Torre Y, Vaporidi K, Lagoudaki ED, et al. Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A (2012) 109(24):9517-22. doi:10.1073/pnas.1119038109
24. Xu F, Kang Y, Zhang H, Piao Z, Yin H, Diao R, et al. Akt1-mediated regulation of macrophage polarization in a murine model of Staphylococcus aureus pulmonary infection. J Infect Dis (2013) 208(3):528-38. doi:10.1093/infdis/jit177
25. Hu X, Herrero C, Li WP, Antoniv TT, Falck-Pedersen E, Koch AE, et al. Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat Immunol (2002) 3(9):859-66. doi:10.1038/ni828
26. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol (2011) 11(11):750-61. doi:10.1038/nri3088
27. Murray PJ, Wynn TA. Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol (2011) 89(4):557-63. doi:10.1189/jlb.0710409
28. Leonard EJ, Skeel AH. Enhancement of spreading, phagocytosis and chemotaxis by macrophage stimulating protein (MSP). Adv Exp Med Biol (1979) 121B:181-94.
29. Wang MH, Iwama A, Skeel A, Suda T, Leonard EJ. The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein. Proc Natl Acad Sci U S A (1995) 92(9):3933-7. doi:10.1073/pnas.92.25.11751
30. Ganesan R, Kolumam GA, Lin SJ, Xie MH, Santell L, Wu TD, et al. Proteolytic activation of pro-macrophage-stimulating protein by hepsin. Mol Cancer Res (2011) 9(9):1175-86. doi:10.1158/1541-7786.MCR-11-0004
31. Correll PH, Iwama A, Tondat S, Mayrhofer G, Suda T, Bernstein A. Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase. Genes Funct (1997) 1(1):69-83. doi:10.1046/j.1365-4624.1997.00009.x
32. Waltz SE, Eaton L, Toney-Earley K, Hess KA, Peace BE, Ihlendorf JR, et al. RON-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J Clin Invest (2001) 108(4):567-76. doi:10.1172/JCI200111881
33. Morrison AC, Wilson CB, Ray M, Correll PH. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol (2004) 172(3):1825-32. doi:10.4049/jimmunol.172.3.1825
34. Chaudhuri A, Wilson NS, Yang B, Paler Martinez A, Liu J, Zhu C, et al. Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associated macrophages. Immunol Cell Biol (2013) 91(7):451-60. doi:10.1038/icb.2013.27
35. Liu QP, Fruit K, Ward J, Correll PH. Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/RON receptor tyrosine kinase. J Immunol (1999) 163(12):6606-13.
36. Chen YQ, Fisher JH, Wang MH. Activation of the RON receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for RON-mediated inhibition of iNOS expression. J Immunol (1998) 161(9):4950-9.
37. Morrison AC, Correll PH. Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages. J Immunol (2002) 168(2):853-60. doi:10.4049/jimmunol.168.2.853
38. Sharda DR, Yu S, Ray M, Squadrito ML, De Palma M, Wynn TA, et al. Regulation of macrophage arginase expression and tumor growth by the RON receptor tyrosine kinase. J Immunol (2011) 187(5):2181-92. doi:10.4049/jimmunol.1003460
39. Mills CD, Xu GY, Johnson KM, McAdoo DJ, Hulsebosch CE. AIDA reduces glutamate release and attenuates mechanical allodynia after spinal cord injury. Neuroreport (2000) 11(14):3067-70. doi:10.1097/00001756-200009280-00007
40. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol (2000) 164(12):6166-73. doi:10.4049/jimmunol.164.12.6166
41. Wells CA, Ravasi T, Faulkner GJ, Carninci P, Okazaki Y, Hayashizaki Y, et al. Genetic control of the innate immune response. BMC Immunol (2003) 4:5. doi:10.1186/1471-2172-4-5
42. Chan EL, Peace BE, Collins MH, Toney-Earley K, Waltz SE. RON tyrosine kinase receptor regulates papilloma growth and malignant conversion in a murine model of skin carcinogenesis. Oncogene (2005) 24(3):479-88. doi:10.1038/sj.onc.1208909
43. Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity (2014) 41(1):49-61. doi:10.1016/j.immuni.2014.06.010